Search
for
Sort by
Research 391–420 of 777
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- Effective treatment of alopecia universalis with oral tofacitinib: A case report
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- The Pathobiology of Skin Aging
- A Comprehensive Review on Skin Pigmentation-Types, Causes, and Treatment
- Alopecia Areata: An Update on Treatment Options for Children
- Regenerative Medicine-Based Treatment for Vitiligo: An Overview
- A Review of Edible Jujube, the Ziziphus jujuba Fruit: A Heath Food Supplement for Anemia Prevalence
- IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives
- Lichen Planopilaris Responsive to a Novel Phytoactive Botanical Treatment: A Case Series
- Enhancing Cancer Therapy with Hyperthermia: Synergistic Effects with Natural Compounds and Conventional Treatments
- Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Stem cell-based therapies for alopecia areata: a narrative review
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs
- Innate type 2 immunity controls hair follicle commensalism by Demodex mites
- An Updated in the Management of Alopecia Areata
- Case Report: A novel KRT74 variant in an eight-year-old boy with alopecia totalis successfully treated with baricitinib
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Ruxolitinib found to cause eyelash growth: a case report
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy